Robin Dewar

7.9k total citations · 1 hit paper
75 papers, 4.6k citations indexed

About

Robin Dewar is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Robin Dewar has authored 75 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Virology, 57 papers in Infectious Diseases and 16 papers in Epidemiology. Recurrent topics in Robin Dewar's work include HIV Research and Treatment (58 papers), HIV/AIDS drug development and treatment (37 papers) and HIV/AIDS Research and Interventions (36 papers). Robin Dewar is often cited by papers focused on HIV Research and Treatment (58 papers), HIV/AIDS drug development and treatment (37 papers) and HIV/AIDS Research and Interventions (36 papers). Robin Dewar collaborates with scholars based in United States, Thailand and Israel. Robin Dewar's co-authors include Julia A. Metcalf, H. Clifford Lane, Richard T. Davey, Michael A. Polis, Joseph A. Kovacs, Frank Maldarelli, Judith Falloon, Joseph W. Adelsberger, Ven Natarajan and Sarah Palmer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and The Journal of Experimental Medicine.

In The Last Decade

Robin Dewar

72 papers receiving 4.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1999 639 citations Richard T. Davey, Christian Yoder et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robin Dewar	3.7k	2.8k	1.3k	891	522	75	4.6k
Véronique Avettand-Fènoël	2.7k 0.7×	2.3k 0.8×	1.3k 1.0×	846 0.9×	331 0.6×	137	4.0k
Rémi Fromentin	3.4k 0.9×	1.9k 0.7×	1.8k 1.4×	873 1.0×	652 1.2×	69	4.2k
Charles Farthing	3.0k 0.8×	1.9k 0.7×	1.7k 1.3×	1.1k 1.2×	373 0.7×	46	4.0k
Birgitta Åsjö	3.1k 0.8×	2.1k 0.8×	1.4k 1.1×	1.0k 1.2×	522 1.0×	75	4.3k
James F. Demarest	3.9k 1.1×	2.0k 0.7×	2.7k 2.1×	1.2k 1.4×	418 0.8×	46	5.1k
Hiroyu Hatano	2.5k 0.7×	1.9k 0.7×	1.2k 0.9×	754 0.8×	548 1.0×	39	3.5k
Mary Zupancic	2.8k 0.8×	1.6k 0.6×	1.4k 1.1×	822 0.9×	450 0.9×	23	3.5k
Linda A. Ehler	4.4k 1.2×	2.2k 0.8×	3.0k 2.3×	1.0k 1.2×	469 0.9×	28	5.2k
Joseph W. Adelsberger	3.0k 0.8×	1.5k 0.5×	2.6k 2.0×	1.1k 1.2×	491 0.9×	59	4.6k
Oren J. Cohen	2.5k 0.7×	1.4k 0.5×	1.7k 1.3×	897 1.0×	438 0.8×	43	3.6k

Countries citing papers authored by Robin Dewar

Since Specialization

Citations

This map shows the geographic impact of Robin Dewar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Dewar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Dewar more than expected).

Fields of papers citing papers by Robin Dewar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Dewar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Dewar. The network helps show where Robin Dewar may publish in the future.

Co-authorship network of co-authors of Robin Dewar

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Dewar. A scholar is included among the top collaborators of Robin Dewar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Dewar. Robin Dewar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brandstetter, Elisabeth, Anne Frosch, Kristina S. Burrack, et al.. (2025). Viral Burden and Illness Severity During Acute SARS-CoV-2 Infection Predict Persistent Long COVID Symptoms. Open Forum Infectious Diseases. 12(2). ofaf048–ofaf048.

Alipanah, Narges, Kevin Delucchi, Lamorna Brown Swigart, et al.. (2024). Novel subtypes of severe COVID-19 respiratory failure based on biological heterogeneity: a secondary analysis of a randomized controlled trial. Critical Care. 28(1). 56–56. 3 indexed citations

Jensen, Tomas Ø., Shaili Gupta, Sean Liu, et al.. (2024). Impact of Baseline SARS-CoV-2 Load in Plasma and Upper Airways on the Incidence of Acute Extrapulmonary Complications of COVID-19: A Multicentric, Prospective, Cohort Study. Clinical Infectious Diseases. 79(6). 1394–1403. 2 indexed citations

Sullivan, Kathleen E., Bruce Thompson, Albert J. Rogers, et al.. (2023). Plasma SARS-CoV-2 Nucleocapsid Antigen Levels Are Associated With In-hospital Mortality in Hospitalized Patients With COVID-19. A6235–A6235.

Donlan, Alexandra N., Z. Jennie, Heather M. Haughey, et al.. (2022). Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial. Open Forum Infectious Diseases. 9(8). ofac343–ofac343. 19 indexed citations

Yang, Jun, Ming Hao, Muhammad Attique Khan, et al.. (2021). A Combination of M50I and V151I Polymorphic Mutations in HIV-1 Subtype B Integrase Results in Defects in Autoprocessing. Viruses. 13(11). 2331–2331. 1 indexed citations

Grossman, Zehava, Wei Shao, Catherine Rehm, et al.. (2018). Early Presence of HIV-1 Subtype C in Washington, D.C.. AIDS Research and Human Retroviruses. 34(8). 680–684. 3 indexed citations

Kassaye, Seble, Zehava Grossman, Chenglong Liu, et al.. (2016). Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DC. Clinical Infectious Diseases. 63(6). 836–843. 33 indexed citations

Tavel, Jorge A., Chiung‐Yu Huang, Julia A. Metcalf, et al.. (2010). Interferon-α Produces Significant Decreases in HIV Load. Journal of Interferon & Cytokine Research. 30(7). 461–464. 33 indexed citations

10.

Imamichi, Hiromi, Ousmane Koita, Djénéba Dabitao, et al.. (2009). Identification and Characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx Recombinant Subtypes in Mali, West Africa. AIDS Research and Human Retroviruses. 25(1). 45–55. 11 indexed citations

11.

Hu, Zonghui, et al.. (2008). A nonparametric likelihood test for detecting discordance between two measurements with application to censored viral load determinations. Statistics in Medicine. 27(22). 4489–4501. 3 indexed citations

12.

Maldarelli, Frank, Sarah Palmer, Martin King, et al.. (2007). ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia. PLoS Pathogens. 3(4). e46–e46. 267 indexed citations

13.

Hengel, Richard L., Maria C. Allende, Robin Dewar, et al.. (2002). Increasing CD4 ⁺ T Cells Specific for Tuberculosis Correlate with Improved Clinical Immunity after Highly Active Antiretroviral Therapy. AIDS Research and Human Retroviruses. 18(13). 969–975. 17 indexed citations

14.

Elbeik, Tarek, W. Gregory Alvord, Rapee Trichavaroj, et al.. (2002). Comparative Analysis of HIV-1 Viral Load Assays on Subtype Quantification: Bayer Versant HIV-1 RNA 3.0 Versus Roche Amplicor HIV-1 Monitor Version 1.5. JAIDS Journal of Acquired Immune Deficiency Syndromes. 29(4). 330–339. 52 indexed citations

15.

Kovacs, Joseph A., Richard A. Lempicki, Igor A. Sidorov, et al.. (2001). Identification of Dynamically Distinct Subpopulations of T Lymphocytes That Are Differentially Affected by HIV. The Journal of Experimental Medicine. 194(12). 1731–1741. 181 indexed citations

16.

Kovacs, Joseph A., Susan Vogel, Randy Stevens, et al.. (2001). Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy. European Journal of Immunology. 31(5). 1351–1360. 48 indexed citations

17.

Davey, Richard T., Robert L. Murphy, Francesco Graziano, et al.. (2000). Immunologic and Virologic Effects of Subcutaneous Interleukin 2 in Combination With Antiretroviral Therapy. JAMA. 284(2). 183–183. 138 indexed citations

18.

Hatano, Hiroyu, Susan Vogel, Christian Yoder, et al.. (2000). Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression. AIDS. 14(10). 1357–1363. 79 indexed citations

19.

Kovacs, Joseph A., Hiromi Imamichi, Susan Vogel, et al.. (2000). Effects of Intermittent Interleukin‐2 Therapy on Plasma and Tissue Human Immunodeficiency Virus Levels and Quasi‐Species Expression. The Journal of Infectious Diseases. 182(4). 1063–1069. 25 indexed citations

20.

Davey, Richard T., Doreen Chaitt, Jeffrey M. Albert, et al.. (1999). A Randomized Trial of High‐ versus Low‐Dose Subcutaneous Interleukin‐2 Outpatient Therapy for Early Human Immunodeficiency Virus Type 1 Infection. The Journal of Infectious Diseases. 179(4). 849–858. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact